期刊文献+

数据挖掘分析线粒体转录延伸因子在胰腺癌中的表达及意义 被引量:5

EXPRESSION AND SIGNIFICANCE OF TEFM IN PANCREATIC CANCER: EVIDENCE FROM DATA MINING
下载PDF
导出
摘要 线粒体转录延伸因子(mitochondrial transcription elongation factor, TEFM)在线粒体基因转录调控中发挥重要作用,但其在胰腺癌中的表达及意义未见系统研究。本研究利用各种肿瘤生物信息学数据库进行数据挖掘分析TEFM基因在胰腺癌及正常胰腺组织中的表达情况,并进一步探讨TEFM基因对胰腺癌患者预后的影响。利用Oncomine数据库分析TEFM基因在正常胰腺组织和胰腺癌组织中m RNA水平的表达变化。通过基因表达谱动态分析(Gene Expression Profiling Interactive Analysis, GEPIA)人体正常组织和其相应的肿瘤组织中TEFM基因的表达差异。经MethHC分析胰腺癌和正常胰腺组织中TEFM基因DNA启动子区甲基化水平的差异。利用OncoLnc对TEFM基因的表达水平与胰腺癌患者生存率作Kaplan-Meier生存分析和Log-rank检验。在String-DB数据库中探索TEFM基因在线粒体基因转录调控中相互作用的基因。结果显示:与正常胰腺组织相比,胰腺癌组织中TEFM基因在m RNA水平呈高表达,且TEFM基因DNA启动子区甲基化水平升高。TEFM基因的表达水平与胰腺癌患者的总体生存时间无显著相关性。线粒体RNA聚合酶(mitochondrial RNA polymerase, POLRMT)与TEFM蛋白有明显的相互作用。大样本数据挖掘能迅速地获取胰腺癌组织中TEFM基因表达的相关信息,为深入研究TEFM基因在胰腺癌发生发展中的作用机制奠定理论基础。 Mitochondrial transcription elongation factor is an important protein factor in the regulation of mitochondrial gene transcription, but there is no systematic study of TEFM expression in Pancreatic cancer. Basedon data mining, the expression of TEFM in Pancreatic cancer and normal tissues and its impact on the prognosis of Pancreatic cancer were analyzed. The mRNA level of TEFM gene in Pancreatic cancer was determined by Oncomine database. The differences in expression of TEFM gene in normal tissues and their corresponding tumor tissues were analyzed by GEPIA. The differences of TEFM gene DNA promoter methylation level in Pancreatic cancer and normal pancreas tissue were analyzed by MethHC analysis. The correlation between the expression level of TEFM gene and the survival time of patients with Pancreatic cancer was analyzed by OncoLnc. The location of the TEFM gene in the cell signal transduction pathway and the upstream and downstream genes associated with it was explored in the String-DB database. Compared with normal pancreatic tissue, the expression level of TEFM gene in pancreatic cancer tissue is higher in mRNA level, the methylation level of TEFM gene DNA promoter region is higher. The expression level of TEFM gene is not significantly correlated with the overall survival time of pancreatic cancer patients. POLRMT protein have obvious interaction with TEFM. Large sample data mining can quickly obtain information about the expression of TEFM in pancreatic cancer, which lays a foundation for further study on the mechanism of TEFM gene in the occurrence and development of pancreatic cancer.
作者 孙美涛 梅雯 王唯斯 李素芬 自加吉 张晓娟 熊伟 SUN Mei-tao;MEI Wen;WANG Wei-si;LI Su-fen;ZI Jia-ji;ZHANG Xiao-juan;XIONG Wei(College of Basic Medical Sciences,Dali University,Dali,Yunnan 671000,China;Department of Basic Medical Sciences and Forensic Medicine,Hangzhou Medical College,Hangzhou,Zhejiang 311300,China;Department of Respiratory Medicine,First People's Hospital of Dali City,Dali,Yunnan 671000,China)
出处 《井冈山大学学报(自然科学版)》 2018年第5期38-43,共6页 Journal of Jinggangshan University (Natural Science)
基金 国家自然科学基金项目(81560458 31601155 31760331) 大理大学大学生创新创业计划项目(S-CXCY-2017-8) 云南省教育厅科学研究基金项目(2016ZDX01 2016ZDX05) 云南省中青年学术和技术带头人后备人才项目(2017HB077)
关键词 胰腺癌 线粒体转录延伸因子 数据挖掘 pancreatic cancer TEFM data mining
  • 相关文献

参考文献3

二级参考文献66

  • 1赵玉沛,陈革.胰腺外科的新进展[J].消化外科,2006,5(2):77-80. 被引量:22
  • 2HIDALGO M.Pancreatic cancer[J].N Engl J Med,2010,362(17):1605-1617.
  • 3VINCENT A,HERMAN J,SCHULICK R,et al.Pancreatic cancer[J].Lancet,2011,378(9791):607-620.
  • 4LI D,XIE K,WOLFF R,et al.Pancreatic cancer[J].Lancet,2004,363(9414):1049-1057.
  • 5BERGER A C,GARCIA M J R,HOFFMAN J P,et al.Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation:a prospective validation by RTOG 9704[J].J Clin Oncol,2008,26(36):5918-5922.
  • 6HESS V,GLIMELIUS B,GRAWE P,et al.CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial[J].Lancet Oncol,2008,9(2):132-138.
  • 7MAITHEL S K,MALONEY S,WINSTON C,et al.Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma[J].Ann Surg Oncol,2008,15(12):3512-3520.
  • 8TAKAHASHI H,OHIGASHI H,ISHIKAWA O,et al.Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival[J].Ann Surg,2010,251(3):461-469.
  • 9GOONETILLEKE K S,SIRIWARDENA A K.Systematic review of carbohydrate antigen(CA 19-9)as a biochemical marker in the diagnosis of pancreatic cancer[J].Eur J Surg Oncol,2007,33(3):266-270.
  • 10LUNDIN J,ROBERTS P J,KUUSELA P,et al.Prognostic significance of serum CA242 in pancreatic cancer.A comparison with CA19-9[J].Anticancer Res,1995,15(5):2181-2186.

共引文献72

同被引文献21

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部